If this is your first visit, be sure to
check out the FAQ by clicking the
link above. You may have to register
before you can post: click the register link above to proceed. To start viewing messages,
select the forum that you want to visit from the selection below.
Google Site Check
Collapse
Google Website Review Code
Collapse
Black Community Speaks Global Ad 1
Collapse
Announcement
Collapse
No announcement yet.
Breakthrough Alzheimer's drug may mark the 'beginning of the end' in decades-long search for treatment to halt cruel memory decline.
Phase three clinical trials have shown that lecanemab, made by Tokyo-based Eisai, can halt the declines in memory and thinking among patients in the earliest stages.
We process personal data about users of our site, through the use of cookies and other technologies, to deliver our services, personalize advertising, and to analyze site activity. We may share certain information about our users with our advertising and analytics partners. For additional details, refer to our Privacy Policy.
By clicking "I AGREE" below, you agree to our Privacy Policy and our personal data processing and cookie practices as described therein. You also acknowledge that this forum may be hosted outside your country and you consent to the collection, storage, and processing of your data in the country where this forum is hosted.
Tweet
Breakthrough Alzheimer's drug may mark the 'beginning of the end' in decades-long search for treatment to halt cruel memory decline.